BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 11099375)

  • 1. Ligand-induced strain in hydrogen bonds of the c-Src SH3 domain detected by NMR.
    Cordier F; Wang C; Grzesiek S; Nicholson LK
    J Mol Biol; 2000 Dec; 304(4):497-505. PubMed ID: 11099375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of backbone motions in ligand binding to the c-Src SH3 domain.
    Wang C; Pawley NH; Nicholson LK
    J Mol Biol; 2001 Nov; 313(4):873-87. PubMed ID: 11697910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
    Larson SM; Davidson AR
    Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heteronuclear NMR studies of the combined Src homology domains 2 and 3 of pp60 c-Src: effects of phosphopeptide binding.
    Tessari M; Gentile LN; Taylor SJ; Shalloway DI; Nicholson LK; Vuister GW
    Biochemistry; 1997 Nov; 36(47):14561-71. PubMed ID: 9398174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT; Serrano L; Wilmanns M
    J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and structural characterization of an independently folding substructure in the src SH3 domain.
    Yi Q; Bystroff C; Rajagopal P; Klevit RE; Baker D
    J Mol Biol; 1998; 283(1):293-300. PubMed ID: 9761691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study.
    Charifson PS; Shewchuk LM; Rocque W; Hummel CW; Jordan SR; Mohr C; Pacofsky GJ; Peel MR; Rodriguez M; Sternbach DD; Consler TG
    Biochemistry; 1997 May; 36(21):6283-93. PubMed ID: 9174343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of a Src-homology 3 (SH3) domain.
    Musacchio A; Noble M; Pauptit R; Wierenga R; Saraste M
    Nature; 1992 Oct; 359(6398):851-5. PubMed ID: 1279434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of the Grb2 N-terminal SH3 domain complexed with a ten-residue peptide derived from SOS: direct refinement against NOEs, J-couplings and 1H and 13C chemical shifts.
    Wittekind M; Mapelli C; Lee V; Goldfarb V; Friedrichs MS; Meyers CA; Mueller L
    J Mol Biol; 1997 Apr; 267(4):933-52. PubMed ID: 9135122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
    Kristensen SM; Siegal G; Sankar A; Driscoll PC
    J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution structure of the diphtheria toxin repressor complexed with cobalt and manganese reveals an SH3-like third domain and suggests a possible role of phosphate as co-corepressor.
    Qiu X; Pohl E; Holmes RK; Hol WG
    Biochemistry; 1996 Sep; 35(38):12292-302. PubMed ID: 8823163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular details of Itk activation by prolyl isomerization and phospholigand binding: the NMR structure of the Itk SH2 domain bound to a phosphopeptide.
    Pletneva EV; Sundd M; Fulton DB; Andreotti AH
    J Mol Biol; 2006 Mar; 357(2):550-61. PubMed ID: 16436281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
    Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
    Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of native topology investigated by multiple unfolding simulations of four SH3 domains.
    Gsponer J; Caflisch A
    J Mol Biol; 2001 May; 309(1):285-98. PubMed ID: 11491296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of the PX domain, a target of the SH3 domain.
    Hiroaki H; Ago T; Ito T; Sumimoto H; Kohda D
    Nat Struct Biol; 2001 Jun; 8(6):526-30. PubMed ID: 11373621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential ligand recognition by the Src and phosphatidylinositol 3-kinase Src homology 3 domains: circular dichroism and ultraviolet resonance Raman studies.
    Okishio N; Tanaka T; Fukuda R; Nagai M
    Biochemistry; 2003 Jan; 42(1):208-16. PubMed ID: 12515556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intertwined dimeric structure for the SH3 domain of the c-Src tyrosine kinase induced by polyethylene glycol binding.
    Cámara-Artigas A; Martín-García JM; Morel B; Ruiz-Sanz J; Luque I
    FEBS Lett; 2009 Feb; 583(4):749-53. PubMed ID: 19185573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of the recognition of the SAMP motif of adenomatous polyposis coli by the Src-homology 3 domain.
    Kaieda S; Matsui C; Mimori-Kiyosue Y; Ikegami T
    Biochemistry; 2010 Jun; 49(25):5143-53. PubMed ID: 20509626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.